Ademi Santiago-Walker

1 ta ish

Johnson & Johnson (United States)

1. Empowering effective biomarker-driven precision oncology: A call to action

   Mark Lawler, Peter Keeling, Olga Kholmanskikh +13

   Sharh maqolaOAOchiq kirishCancer Genomics and DiagnosticsEuropean Journal of Cancer20240 iqtibos

   ABIABI:AkademIndex/2024.review-article.000008